This week learn more about CDC's strategies to reduce waterborne diseases; the US change to a trivalent influenza vaccine; new data for Merck's pneumococcal vaccine; and how PCR testing can influence a patient diagnosis and outcome.
Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile
C difficile, Antimicrobials, and the Patients Most Affected
Contagion's 2024 Top Stories: C difficile
Could the Flight or Fight Response Trigger Severe C difficile?
Top 5 Infectious Disease News Stories Week of December 14-20
While Hospital-Acquired C difficile Cases Have Decreased, Community-Acquired Cases Have Risen